CVS insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
James Clark SVP, Cont & Chief Acct Officer	454	$90.98	1.0%	43K	Jun 26, 2026	Jun 29, 2026

What stands out

Larry Robbins sold 41% of vested holdings: 3.37M shares for $317M, none under a disclosed plan.Largest sale, May 19, 2026

Tilak Mandadi sold $6.2M of stock with no disclosed trading plan. The filings don't state a reason.Largest such sale, May 8, 2026

Percentages cover 11 of 22 officers and directors. 11 are left out

Left out: Prem Shah, David Joyner, Heidi Capozzi, Tilak Mandadi, Samrat Khichi, Roger Farah, Anne Finucane, Steven Nelson, Brian Newman and Amy Compton-Phillips (holdings couldn't be fully reconciled); John Gallina (held no vested shares at the start).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

SoldRest of starting stake

Larry Robbins

Director

41% · $317MNo plan disclosed

Tilak Mandadi

EVP, Chief Exp & Tech Officer

Sold $6.2M (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$6.2MNo plan disclosed

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the CVS Health CEO selling stock?

No. David Joyner reported no open-market sales in the past 12 months.

Why are CVS Health insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 100% had no disclosed plan. A trading plan schedules sales in advance.

Are any CVS Health insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did CVS Health insiders sell?

About 40% overall. As a group they still hold 60% of their starting shares. That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold2 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Larry Robbins Director	$317M 3.37M shares	41%	No plan disclosed
Tilak Mandadi EVP, Chief Exp & Tech Officer	$6.2M 70K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed

The full ownership picture12 of 22 insiders fully reconciled · 22 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

Larry Robbins

Director

8.20M

−3.37M

4.82M

59%

Vesting, gifts, unvested awards and holding lines for Larry Robbins

0shares vested or exercised

0gifted (net of own trusts)

8.7K → 27Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Glenview Investment Funds	Common Stock	8,196,799	4,824,799

David Brown II

Director

126K

129K

no sales

Vesting, gifts, unvested awards and holding lines for David Brown II

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	125,997	129,316

Prem Shah

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -20,376 shares on Mar 31, 2026 (Direct). See the filing Sales and other transactions for Prem Shah are complete.

EVP and Group President

n/a

Vesting, gifts, unvested awards and holding lines for Prem Shah

0shares vested or exercised

0gifted (net of own trusts)

−1.7Kwithheld by the company for taxes

68K → 70Kunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -20,376 shares on Mar 31, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	60,632	64,356
Direct includes unvested RSUs, amount not disclosed	Common Stock (restricted)	58,166	62,852
Direct	ESOP Common Stock	4,969	4,969

Additional holdings last reported Apr 1, 2023, not confirmed since: 3,014 shares. Not included in any total or percentage on this page.

Direct, Common Stock (pep): 3,014 shares, last reported Apr 1, 2023

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,313	$81.28	Apr 1, 2029	$77K
19,064	$87.51	Apr 1, 2030	$113K
19,149	$111.45	Apr 1, 2031	$0
17,720	$112.86	Aug 31, 2028	$0
27,720	$151.64	Apr 1, 2032	$0
564	$93.32	Apr 1, 2025	$75
59,382	$111.47	Apr 1, 2033	$0
62,695	$79.56	Apr 1, 2034	$871K
746,268	$71.82	Nov 30, 2031	$16.1M
9,469	$54.19	Apr 1, 2029	$372K
28,596	$58.34	Apr 1, 2030	$1.0M
26,580	$75.24	Aug 31, 2028	$484K
28,723	$74.30	Apr 1, 2031	$550K
41,580	$101.09	Apr 1, 2032	$0
89,073	$74.31	Apr 1, 2033	$1.7M
112,289	$67.98	Apr 1, 2035	$2.9M
161,676	$71.82	Mar 31, 2036	$3.5M

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

David Joyner

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +28,382 shares on Apr 1, 2026 (Direct). See the filing Sales and other transactions for David Joyner are complete.

President, CEO and Chair, Director

n/a

Vesting, gifts, unvested awards and holding lines for David Joyner

0shares vested or exercised

0gifted (net of own trusts)

−10Kwithheld by the company for taxes

83K → 243Kunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
New Form 3 filed 2023-02-03; earlier filings set aside.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +28,382 shares on Apr 1, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	51,940	70,349
Direct includes unvested RSUs, amount not disclosed	Common Stock (Restricted)	44,241	44,241

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
51,959	$74.31	Apr 1, 2033	$994K
1,000,000	$71.82	Nov 30, 2031	$21.6M
226,138	$67.98	Apr 1, 2035	$5.8M

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

Heidi Capozzi

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +20,885 shares on Nov 30, 2025 (Direct). See the filing Sales and other transactions for Heidi Capozzi are complete.

EVP and Chief People Officer

n/a

Vesting, gifts, unvested awards and holding lines for Heidi Capozzi

0shares vested or exercised

0gifted (net of own trusts)

−11Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +20,885 shares on Nov 30, 2025 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	13,023
Trust	Common Stock	85	85
Direct includes unvested RSUs, amount not disclosed	Common Stock (Restricted)	95,310	84,450

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
49,906	$67.98	Apr 1, 2035	$1.3M
64,670	$71.82	Mar 31, 2036	$1.4M

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

Tilak Mandadi

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +16,708 shares on Nov 30, 2025 (Direct). See the filing Sales and other transactions for Tilak Mandadi are complete.

EVP, Chief Exp & Tech Officer

n/a

−70K

n/a

Vesting, gifts, unvested awards and holding lines for Tilak Mandadi

0shares vested or exercised

0gifted (net of own trusts)

−10Kwithheld by the company for taxes

299K → 387Kunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +16,708 shares on Nov 30, 2025 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	63,952	10,133

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
67,920	$79.56	Apr 1, 2034	$943K
96,496	$74.31	Apr 1, 2033	$1.8M
87,336	$67.98	Apr 1, 2035	$2.2M
143,712	$71.82	Mar 31, 2036	$3.1M

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

Samrat Khichi

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +15,961 shares on Feb 28, 2026 (Direct). See the filing Sales and other transactions for Samrat Khichi are complete.

EVP, CPO and General Counsel

n/a

Vesting, gifts, unvested awards and holding lines for Samrat Khichi

0shares vested or exercised

0gifted (net of own trusts)

−11Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +15,961 shares on Feb 28, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	21,700	33,421
Direct includes unvested RSUs, amount not disclosed	Common Stock (Restricted)	41,569	38,139

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
66,805	$74.31	Apr 1, 2033	$1.3M
52,246	$79.56	Apr 1, 2034	$726K
68,621	$67.98	Apr 1, 2035	$1.7M
80,838	$71.82	Mar 31, 2036	$1.7M

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

Roger Farah

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +25,062 shares on Nov 30, 2025 (Direct). See the filing Sales and other transactions for Roger Farah are complete.

Director

n/a

Vesting, gifts, unvested awards and holding lines for Roger Farah

0shares vested or exercised

0gifted (net of own trusts)

−9.7Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +25,062 shares on Nov 30, 2025 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	4,124	19,438
Direct includes unvested RSUs, amount not disclosed	Common Stock (Restricted)	50,125	50,125

Anne Finucane

Holdings couldn't be fully reconciled. Filings report each grant's shares as the balance instead of a running total. See the filing Sales and other transactions for Anne Finucane are complete.

Director

n/a

Vesting, gifts, unvested awards and holding lines for Anne Finucane

0shares vested or exercised

0gifted (net of own trusts)

27K → 62Kunvested awards, start → end

Holdings couldn't be fully reconciled. Filings report each grant's shares as the balance instead of a running total. The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	692	591
Finucane Family Trust	Common Stock	25,198	25,198
Trust	Common Stock	22,156	22,156

Michael Mahoney

Director

46K

no sales

Vesting, gifts, unvested awards and holding lines for Michael Mahoney

0shares vested or exercised

0gifted (net of own trusts)

2.5K → 14Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	6,345	6,345
Direct	Common Stock (By Trust)	39,356	39,356
Children's Trusts	Common Stock (By Trust)	210	210

Fernando Aguirre

Director

40K

11K

no sales

Vesting, gifts, unvested awards and holding lines for Fernando Aguirre

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	39,150	10,513
Spouse and Children	Common Stock	668	668

James Clark

Minor difference of -86 shares. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed.

SVP, Cont & Chief Acct Officer

36K

43K

no sales

Vesting, gifts, unvested awards and holding lines for James Clark

0shares vested or exercised

0gifted (net of own trusts)

−3.9Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	11,240	15,457
Direct includes unvested RSUs, amount not disclosed	Common Stock (restricted)	24,707	27,606

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,033	$117.08	Apr 3, 2024	$0
5,009	$93.32	Apr 1, 2025	$667
16,160	$81.28	Apr 1, 2029	$197K
11,438	$87.51	Apr 1, 2030	$68K
8,063	$111.45	Apr 1, 2031	$0
4,504	$151.64	Apr 1, 2032	$0
6,433	$111.47	Apr 1, 2033	$0
9,050	$78.05	Apr 3, 2024	$139K
24,240	$54.19	Apr 1, 2029	$952K
17,157	$58.34	Apr 1, 2030	$602K
12,094	$74.30	Apr 1, 2031	$232K
6,756	$101.09	Apr 1, 2032	$0
9,649	$74.31	Apr 1, 2033	$185K
11,976	$71.82	Mar 31, 2036	$259K

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

Reconciliation: minor difference of -86 shares. Difference is under 0.5% of holdings.

Steven Nelson

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +5,332 shares on Apr 1, 2026 (Direct). See the filing Sales and other transactions for Steven Nelson are complete.

EVP and President, Aetna

n/a

Vesting, gifts, unvested awards and holding lines for Steven Nelson

0shares vested or exercised

0gifted (net of own trusts)

−2.4Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +5,332 shares on Apr 1, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	2,900
Trust	Common Stock (By Trust)	24	24
Direct includes unvested RSUs, amount not disclosed	Common Stock (Restricted)	21,329	43,606

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
124,378	$71.82	Nov 30, 2031	$2.7M
90,455	$67.98	Apr 1, 2035	$2.3M
143,712	$71.82	Mar 31, 2036	$3.1M

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

Guy Sansone

Director

12K

15K

no sales

Vesting, gifts, unvested awards and holding lines for Guy Sansone

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	12,007	15,106

Jeffrey Balser

Director

12K

16K

no sales

Vesting, gifts, unvested awards and holding lines for Jeffrey Balser

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	11,884	15,717

Scott Kirby

Director

11K

14K

no sales

Vesting, gifts, unvested awards and holding lines for Scott Kirby

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	11,335	14,434

Leslie Norwalk

Director

4.3K

7.4K

no sales

Vesting, gifts, unvested awards and holding lines for Leslie Norwalk

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	4,277	7,376

Douglas Shulman

Director

4.3K

5.9K

no sales

Vesting, gifts, unvested awards and holding lines for Douglas Shulman

0shares vested or exercised

0gifted (net of own trusts)

0 → 1.4Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	4,277	5,929

Alecia Decoudreaux

Director

no sales

Vesting, gifts, unvested awards and holding lines for Alecia Decoudreaux

0shares vested or exercised

0gifted (net of own trusts)

73K → 155Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	2,970	2,970

Brian Newman

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +5,465 shares on May 31, 2026 (Direct). See the filing Sales and other transactions for Brian Newman are complete.

EVP, Chief Financial Officer

n/a

Vesting, gifts, unvested awards and holding lines for Brian Newman

0shares vested or exercised

0gifted (net of own trusts)

−2.5Kwithheld by the company for taxes

22K → 41Kunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +5,465 shares on May 31, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	21	3,008
Child	Common Stock (By GRAT)	22	22
Shares held by family trust	Common Stock (By Trust)	8	8

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
94,786	$64.04	May 31, 2035	$2.8M
125,748	$71.82	Mar 31, 2036	$2.7M

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

Amy Compton-Phillips

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +17,175 shares on May 31, 2026 (Direct). See the filing Sales and other transactions for Amy Compton-Phillips are complete.

EVP, Chief Medical Officer

n/a

Vesting, gifts, unvested awards and holding lines for Amy Compton-Phillips

0shares vested or exercised

0gifted (net of own trusts)

−7.6Kwithheld by the company for taxes

53K → 59Kunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +17,175 shares on May 31, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	9,557
Trust	Common Stock	35	35

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
27,081	$64.04	May 31, 2035	$796K
35,928	$71.82	Mar 31, 2036	$777K

Estimate: options held × ($93.45 − strike price), using the most recent insider trade price on Form 4 (May 21, 2026), not a market close.

John Gallina

Director

582

no sales

Vesting, gifts, unvested awards and holding lines for John Gallina

0shares vested or exercised

0gifted (net of own trusts)

0 → 1.4Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	582

12 of 22 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (11 exactly, 1 with a minor or footnoted difference). For 10 we show sales but not holdings; the ! icon on their rows explains why. Percentages cover 11 of 22 officers and directors. Left out: Prem Shah, David Joyner, Heidi Capozzi, Tilak Mandadi, Samrat Khichi, Roger Farah, Anne Finucane, Steven Nelson, Brian Newman and Amy Compton-Phillips (holdings couldn't be fully reconciled); John Gallina (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$324M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $324M across 3,441,551 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $324M

Sales with no 10b5-1 plan and no tax reference in the filing. $317M of it is Larry Robbins. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Larry Robbins, May 19, 2026

Taxes

70,356 shares ($5.6M) were withheld by the company for taxes, which isn't a market sale.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Larry Robbins Director	3.37M	$317M	0%	98%	May 19, 2026 to May 21, 2026
Tilak Mandadi EVP, Chief Exp & Tech Officer	70K	$6.2M	0%	2%	May 8, 2026 to May 8, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$324M	$0	$0	$324M
Jun 2026	$0	$0	$0	$0
Jul 2026	$0	$0	$0	$0
Aug 2026	$0	$0	$0	$0
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

More than usual: about 3x the 5-year average. 2 insiders sold; the average is 5 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	3.44M	2	$324M
Oct 9, 2025 1 year earlier	3.77M	3	$255M
Oct 9, 2024 2 years earlier	20K	1	$2.3M
Oct 10, 2023 3 years earlier	109K	2	$15.5M
Oct 10, 2022 4 years earlier	530K	7	$78.4M
Oct 10, 2021 5 years earlier	680K	10	$79.2M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty10 insiders whose holdings couldn't be fully reconciled

Prem Shah: holdings couldn't be fully reconciled (difference of -14,921 shares). Balance changed without a matching transaction, and the footnote does not state the amount: -20,376 shares on Mar 31, 2026 (Direct). Filing, Mar 31, 2026

David Joyner: holdings couldn't be fully reconciled (difference of 28,382 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +28,382 shares on Apr 1, 2026 (Direct). Filing, Apr 1, 2026

Heidi Capozzi: holdings couldn't be fully reconciled (difference of 2,942 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +20,885 shares on Nov 30, 2025 (Direct). Filing, Nov 30, 2025

Tilak Mandadi: holdings couldn't be fully reconciled (difference of 25,941 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +16,708 shares on Nov 30, 2025 (Direct). Filing, Nov 30, 2025

Samrat Khichi: holdings couldn't be fully reconciled (difference of 7,187 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +15,961 shares on Feb 28, 2026 (Direct). Filing, Feb 28, 2026

Roger Farah: holdings couldn't be fully reconciled (difference of 25,062 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +25,062 shares on Nov 30, 2025 (Direct). Filing, Nov 30, 2025

Anne Finucane: holdings couldn't be fully reconciled (difference of -692 shares). Filings report each grant's shares as the balance instead of a running total. Filing, Nov 20, 2025

Steven Nelson: holdings couldn't be fully reconciled (difference of 5,332 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +5,332 shares on Apr 1, 2026 (Direct). Filing, Apr 1, 2026

Brian Newman: holdings couldn't be fully reconciled (difference of 5,465 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +5,465 shares on May 31, 2026 (Direct). Filing, May 31, 2026

Amy Compton-Phillips: holdings couldn't be fully reconciled (difference of 17,175 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +17,175 shares on May 31, 2026 (Direct). Filing, May 31, 2026

James Clark: minor difference of -86 shares. Difference is under 0.5% of holdings.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,800 filings from SEC EDGAR, and how we read them

All 1,800 Forms 3, 4 and 5 filed for CVS Health (SEC CIK 64803) from Dec 16, 2002 to Jun 29, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages. 52 older filings exist only on paper and could not be read.

Probable 2-for-1 stock split on or before Feb 28, 2004 (first filing that shows post-split balances). Splits aren't reported as transactions; 3 holding lines changed by exactly this ratio, so earlier share counts are restated.

Probable 2-for-1 stock split on or before Jul 6, 2005 (first filing that shows post-split balances). Splits aren't reported as transactions; 17 holding lines changed by exactly this ratio, so earlier share counts are restated.

Probable 2-for-3 stock split on or before Feb 28, 2024 (first filing that shows post-split balances). Splits aren't reported as transactions; 2 holding lines changed by exactly this ratio, so earlier share counts are restated.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (67)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Thomas Cowhey	Apr 3, 2025	91,297 shares, last reported balance as of Apr 1, 2025
Jean Millon	Nov 25, 2024	112,217 shares, last reported balance as of Nov 21, 2024
Nancy Deparle	Nov 25, 2024	34,169 shares, last reported balance as of Nov 21, 2024
Mary Schapiro	Nov 25, 2024	11,844 shares, last reported balance as of Nov 21, 2024
Edward Ludwig	May 2, 2024	32,709 shares, last reported balance as of May 2, 2024
Karen Lynch	Apr 3, 2024	407,530 shares, last reported balance as of Apr 1, 2024
Laurie Havanec	Apr 3, 2024	46,979 shares, last reported balance as of Apr 1, 2024
Sreekanth Chaguturu	Apr 3, 2024	34,878 shares, last reported balance as of Apr 1, 2024
Brian Kane	Apr 3, 2024	13,176 shares, last reported balance as of Apr 1, 2024
Daniel Finke	Apr 4, 2023	29,565 shares, last reported balance as of Apr 1, 2023
Shawn Guertin	Apr 4, 2023	29,311 shares, last reported balance as of Apr 1, 2023
Michelle Peluso	Apr 4, 2023	119,617 shares, last reported balance as of Apr 1, 2023
Thomas Moriarty	Jan 4, 2023	326,073 shares, last reported balance as of Dec 31, 2022
William Weldon	Nov 21, 2022	1,259 shares, last reported balance as of Nov 17, 2022
Alan Lotvin	Aug 5, 2022	77,002 shares, last reported balance as of Aug 4, 2022
David Dorman	May 13, 2022	123,517 shares, last reported balance as of May 11, 2022
Tony White	May 13, 2022	25,239 shares, last reported balance as of May 11, 2022
Jonathan Roberts	Apr 5, 2022	332,796 shares, last reported balance as of Apr 1, 2022
Troyen Brennan	Apr 5, 2022	165,783 shares, last reported balance as of Apr 3, 2022
Larry Merlo	Jun 2, 2021	712,912 shares, last reported balance as of May 31, 2021
Eva Boratto	May 6, 2021	83,113 shares, last reported balance as of May 4, 2021
Lisa Bisaccia	Apr 2, 2021	63,025 shares, last reported balance as of Apr 1, 2021
Neela Montgomery	Apr 2, 2021	19,668 shares, last reported balance as of Apr 1, 2021
Joshua Flum	Mar 2, 2021	24,801 shares, last reported balance as of Feb 28, 2021
Jonathan Mayhew	Dec 4, 2020	9,935 shares, last reported balance as of Dec 2, 2020
Derica Rice	Mar 3, 2020	33,948 shares, last reported balance as of Feb 28, 2020
Richard Swift	Nov 22, 2019	4,891 shares, last reported balance as of Nov 20, 2019
Richard Bracken	Nov 22, 2019	10,232 shares, last reported balance as of Nov 20, 2019
Mark Bertolini	Nov 22, 2019	9,182 shares, last reported balance as of Nov 20, 2019
Mark Bertolini	Nov 22, 2019	66,715 shares, last reported balance as of Nov 20, 2019
Kevin Hourican	Apr 3, 2019	14,765 shares, last reported balance as of Apr 1, 2019
David Denton	Nov 30, 2018	72,133 shares, last reported balance as of Nov 29, 2018
Helena Foulkes	Feb 21, 2018	67,418 shares, last reported balance as of Feb 16, 2018
Andrew Sussman	Apr 4, 2017	20,643 shares, last reported balance as of Apr 3, 2017
Stephen Gold	Apr 4, 2017	57,514 shares, last reported balance as of Apr 3, 2017
Robert Kraft	Apr 4, 2017	71,992 shares, last reported balance as of Apr 3, 2017
Per Lofberg	Jan 5, 2015	167,213 shares, last reported balance as of Jan 2, 2015
Mark Cosby	Oct 1, 2013	50,900 shares, last reported balance as of Sep 30, 2013
Kristen Williams	May 10, 2013	48,879 shares, last reported balance as of May 9, 2013
Laird Daniels	Apr 3, 2013	33,706 shares, last reported balance as of Apr 1, 2013
PICCOLO C A	Dec 17, 2012	120,974 shares, last reported balance as of Dec 14, 2012
Marian Heard	Nov 9, 2012	7,569 shares, last reported balance as of Nov 8, 2012
Douglas Sgarro	May 14, 2012	62,823 shares, last reported balance as of May 11, 2012
Stuart McGuigan	Mar 20, 2012	28,078 shares, last reported balance as of Mar 16, 2012
Edwin Banks	Mar 16, 2012	16,125 shares, last reported balance as of Mar 15, 2012
Terrence Murray	Nov 4, 2011	64,195 shares, last reported balance as of Nov 2, 2011
Terrence Murray	Nov 4, 2011	5,827 shares, last reported balance as of Nov 5, 2008
Thomas Ryan	Apr 5, 2011	1,435,869 shares, last reported balance as of Apr 3, 2011
Thomas Ryan	Apr 5, 2011	44,693 shares, last reported balance as of Apr 3, 2011
Sara Finley	Feb 22, 2011	39,163 shares, last reported balance as of Feb 18, 2011
Sheli Rosenberg	Feb 11, 2011	84,697 shares, last reported balance as of Dec 31, 2010
William Joyce	Nov 5, 2010	12,260 shares, last reported balance as of Nov 4, 2009
David Rickard	Dec 16, 2009	207,096 shares, last reported balance as of Dec 14, 2009
Howard McLure	Nov 4, 2009	158,043 shares, last reported balance as of Nov 2, 2009
Michael Ferdinandi	Aug 20, 2009	49,391 shares, last reported balance as of Aug 19, 2009
Chris Bodine	Feb 20, 2009	210,963 shares, last reported balance as of Feb 18, 2009
Paula Price	Feb 14, 2008	13,108 shares, last reported balance as of Feb 12, 2008
Edwin Crawford	Oct 31, 2007	90,381 shares, last reported balance as of Oct 29, 2007
William Spalding	Jun 19, 2007	15,578 shares, last reported balance as of Jun 18, 2007
Roger Headrick	May 24, 2007	217,641 shares, last reported balance as of May 23, 2007
Alfred Verrecchia	Mar 8, 2007	No balance on record
Don Cornwell	Dec 27, 2006	3,277 shares, last reported balance as of May 11, 2006
Thomas Gerrity	Nov 13, 2006	45,640 shares, last reported balance as of Nov 9, 2006
Stanley Goldstein	May 15, 2006	460,645 shares, last reported balance as of May 11, 2006
Gregory Weishar	Apr 5, 2006	51,191 shares, last reported balance as of Apr 3, 2006
Larry Solberg	Feb 21, 2006	43,936 shares, last reported balance as of Feb 16, 2006
Terry Lautenbach	May 14, 2004	74,440 shares, last reported balance as of Dec 9, 2003

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

CVS Health insiders sold $324M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the CVS Health CEO selling stock?

Why are CVS Health insiders selling?

Are any CVS Health insiders buying?

How much of their stake did CVS Health insiders sell?

The evidence

No plan disclosed · $324M

Taxes

Sales by month